Protagonist Therapeutics Inc (PTGX)
Financing Cash Flow
$41.61M
TTM · Period ending: · USD
PTGX Financing Cash Flow
Latest reported$41.61Mperiod ending
Latest reported$41.61Mperiod ending
PTGX TTM Cash from Financing ($17.42M → $41.61M)
TTM financing cash flow
High-resolution chart · PNG
PTGX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 41,613,000 | |
| 34,795,000 | |
| 22,864,000 | |
| 24,058,000 | |
| 30,450,000 | |
| 30,097,000 | |
| 25,853,000 | |
| 22,349,000 | |
| 45,613,000 | |
| 151,213,000 | |
| 170,477,000 | |
| 170,503,000 | |
| 135,868,000 | |
| 28,376,000 | |
| 18,838,000 | |
| 20,458,000 | |
| 21,159,000 | |
| 145,869,000 | |
| 129,923,000 | |
| 254,731,000 | |
| 261,019,000 | |
| 248,206,000 | |
| 247,626,000 | |
| 130,424,000 | |
| 147,992,000 | |
| 46,045,000 | |
| 46,036,000 | |
| 36,736,000 | |
| 34,531,000 | |
| 23,975,000 | |
| 24,115,000 | |
| 88,698,000 | |
| 65,697,000 | |
| 65,710,000 | |
| 65,554,000 | |
| -360,000 | |
| 84,887,000 | |
| 84,050,000 | |
| 106,307,000 | |
| 107,159,000 | |
| 39,243,000 | |
| 40,048,000 | |
| 17,419,000 |